Journal for ImmunoTherapy of Cancer Issues Research Articles in September 2024 Edition
October 03, 2024
October 03, 2024
MILWAUKEE, Wisconsin, Oct. 3 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, published research articles on the following topics in its September 2024 edition (Vol. 12, Issue 9):
Clinical/translational cancer immunotherapy
* Original research: Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in p . . .
Clinical/translational cancer immunotherapy
* Original research: Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in p . . .